Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
33.23
-0.97 (-2.84%)
At close: Dec 23, 2025, 4:00 PM EST
32.60
-0.63 (-1.90%)
After-hours: Dec 23, 2025, 6:08 PM EST
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $2.58 billion as of December 23, 2025. Its market cap has increased by 96.21% in one year.
Market Cap
2.58B
Enterprise Value
2.09B
1-Year Change
96.21%
Ranking
Category
Stock Price
$33.23
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $2.58B, an increase of 2,208.31%. That is a compound annual growth rate of 38.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 2.65B | 121.64% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |